drugset

drugset / Trial / NCT00301535

A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery

NCT00301535 ↗

Phase 2 Unknown 60 enrolled Biopure Corporation

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if Hemopure® will enhance tissue preservation during Cardiopulmonary Bypass surgery.

Timeline

Start: 2006-02
Primary completion: 2008-07
Completion: 2008-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HBOC-201	Protein / enzyme biologic	—	—

Indications